Myocardial Solutions (MSI) featured MyoStrain® in a satellite symposium at the first ever International Cardio-Oncology Summit 2020, a joint CardioTox and Global Cardio-Oncology Society (GCOS) initiative attracting oncologists, cardiologists, radiologists and pharmacists from around the world to ...
MyoStrain® was included in a new article published in the Journal of Cardiovascular Magnetic Resonance (JCMR) by the Society of Cardiovascular Magnetic Resonance (SCMR). The paper provides specific and detailed recommendations on the use of cardiovascular magnetic resonance (CMR) protocols for...
Myocardial Solutions (“MSI”) technology MyoStrain® was featured in five unique abstracts and e-poster presentations at the European Society of Cardiology (ESC) virtual congress event from August 29th to September 2nd. The abstracts discussed the diagnostic value and clinical impact of MyoStrain...
Myocardial Solutions, Inc. (“MSI”) was recognized as the Most Innovative Cardiology Software Company of 2020.The award to MSI was published in Acquisition International’s (“AI Global”) annual Global Excellence Awards issue for the month of August. AI Global is a magazine publisher based in the...
Myocardial Solutions, Inc. (“MSI”) and United Imaging, Inc. (“United Imaging”) have formed a strategic partnership to open the cancer care and cardiology market for rapid imaging enabling the detection and management of cardiac diseases and the effects of cancer therapies on the heart...
